Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
David A. Braun(Yale Cancer Center), Catherine J. Wu(Dana-Farber Cancer Institute), David F. McDermott(Beth Israel Deaconess Medical Center), Ang Cui(Harvard University), Steven L. Chang(Brigham and Women's Hospital), Erica Pimenta(Harvard University), Thomas Denize(Harvard University), Michelle S. Hirsch(Perinatal Institute), Gabrielle Bouchard(Dana-Farber Cancer Institute), Ziad Bakouny(Dana-Farber Cancer Institute), Kathleen M. Mahoney(Beth Israel Deaconess Medical Center), Yue Hou(Inner Mongolia Medical University), Arlene H. Sharpe(Brigham and Women's Hospital), John A. Steinharter(Memorial Sloan Kettering Cancer Center), Sabina Signoretti(Brigham and Women's Hospital), Laure Hirsch(Harvard University), Toni K. Choueiri(Harvard University), Rafael A. Irizarry(Johns Hopkins University), Kelly P. Burke(Harvard University), Kenneth J. Livak(Broad Institute), David L. Cookmeyer(Harvard University), Maxine Sun(Université de Montréal), Bradley A. McGregor(Harvard University), Wenxin Xu(Dana-Farber Cancer Institute), Lars Rønn Olsen(Copenhagen University Hospital), Shuqiang Li(Anhui Normal University), Nicholas R. Schindler(Dana-Farber Cancer Institute), Sachet A. Shukla(Broad Institute), Teddy Huang(Dana-Farber Cancer Institute), Lucas Pomerance(Harvard University), Christina B. Pedersen(Copenhagen University Hospital), Satyen H. Gohil(Broad Institute), Derin B. Keskin(Dana-Farber Cancer Institute), Juliet Forman(Broad Institute), Kelly Street(University of Southern California)
Cited by 515
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
The Immune Landscape of Cancer
|Immunity|2018|6.2k
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k